ARKF Performance — ARK Fintech Innovation ETF
Data updated: 2026-10-06
ARKF returned −16.89% year to date and −25.92% over one year to Jul 2026. Annualised returns are +18.05% over 3 years and −4.74% over 5 years. Against its US Mid-Cap Growth category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $165, against $139 for the category, and to $74 over one year, against $110. Volatility over the past three years was 38.35% a year. In the 12 months to Jul 2026 the fund lost a net $294.7M, and assets reached $700.81M.
ARKF Growth of $100
What $100 invested in ARK Fintech Innovation ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.
| Period | ARKF | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $74 | $110 |
| 3 years (Aug 2023 – Jul 2026) | $165 | $139 |
| 5 years (Aug 2021 – Jul 2026) | $78 | $121 |
| Since data start (Feb 2020 – Jul 2026) | $158 | $182 |
ARKF Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −16.89% |
| 1 year | −25.92% |
| 3 years (annualised) | +18.05% |
| 5 years (annualised) | −4.74% |
ARKF Annual Returns
Calendar-year total returns of ARK Fintech Innovation ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | −16.89% |
| 2025 | +28.94% |
| 2024 | +34.46% |
| 2023 | +92.86% |
| 2022 | −64.99% |
| 2021 | −17.71% |
| 2020 (Feb–Dec) | +97.05% |
ARKF Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −9.4% | −9.9% | −2.5% | +8.5% | +4.5% | −8.6% | +0.6% | — | — | — | — | — |
| 2025 | +12.4% | −8.6% | −12.2% | +8.1% | +13.9% | +22.1% | +6.9% | −0.2% | +6.0% | −0.2% | −12.6% | −3.4% |
| 2024 | −7.3% | +12.2% | +5.8% | −11.6% | −0.5% | +4.5% | −2.3% | +3.9% | +5.4% | +3.6% | +26.9% | −5.4% |
| 2023 | +28.7% | −2.2% | +4.5% | −6.2% | +10.1% | +7.6% | +15.6% | −12.7% | −8.1% | −6.8% | +30.3% | +17.1% |
| 2022 | −20.6% | −6.6% | −4.1% | −26.9% | −11.7% | −17.6% | +15.8% | −2.3% | −11.9% | +8.2% | −2.9% | −11.7% |
| 2021 | +5.0% | +5.9% | −7.8% | +2.7% | −4.9% | +8.9% | −6.4% | +6.4% | −8.3% | +8.1% | −13.0% | −12.1% |
| 2020 | — | −2.5% | −16.8% | +18.3% | +16.7% | +11.6% | +14.5% | +11.4% | −1.9% | +3.2% | +14.1% | +7.0% |
ARKF Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 38.35%
- 3-year Sharpe ratio: 0.35 (vs 4.5% risk-free rate)
- Best month: +30.33% (Nov 2023)
- Worst month: −12.70% (Aug 2023)
ARKF Fund Flows
Monthly money in and out of ARK Fintech Innovation ETF, from SEC Form N-PORT.
- 12-month net flow: −$294.7M
- 12-month gross sales (incl. reinvestments): $1.6B
- Sales ÷ redemptions: 0.85×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $28.5M | −$28.5M |
| Jun 2026 | $0 | $40.3M | −$40.3M |
| May 2026 | $11K | $28.9M | −$28.9M |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $206 | $21.9M | −$21.9M |
| Feb 2026 | $97.4M | $157.7M | −$60.4M |
| Jan 2026 | $472.3M | $440.4M | $32.0M |
| Dec 2025 | $0 | $0 | $0 |
| Nov 2025 | $66.4M | $51.1M | $15.3M |
| Oct 2025 | $50.5M | $181.2M | −$130.7M |
| Sep 2025 | $743.3M | $760.9M | −$17.7M |
| Aug 2025 | $190.2M | $203.7M | −$13.6M |
ARKF Assets Under Management
Net assets of ARK Fintech Innovation ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $700.81M |
| 2026-04-30 | $827.52M |
| 2026-01-30 | $963.41M |
| 2025-10-31 | $1.28B |
| 2025-07-31 | $1.36B |
| 2025-04-30 | $904.31M |
| 2025-01-31 | $1.12B |
| 2024-10-31 | $890.01M |
| 2024-07-31 | $828.21M |
| 2024-04-30 | $970.95M |
| 2024-01-31 | $1.03B |
| 2023-10-31 | $752.63M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.